Skip to main content

Nutrition Studies in Long-Chain Fatty Acid Oxidation Disorders: Diet Composition and Monitoring

  • Chapter
Nutrition Management of Inherited Metabolic Diseases

Abstract

In patients with long-chain fatty acid oxidation disorders (LCFAOD):

  • Energy requirements may differ from that of the normal population.

  • Diets high in lean sources of protein appear to increase lean body mass and decrease liver lipid content.

  • Plasma acylcarnitine profiles improve when dietary long-chain fat is restricted and MCT is supplemented.

  • MCT improves exercise tolerance.

  • Low-fat diets may cause deficiencies of essential fatty acids, DHA, and/or fat-soluble vitamins.

  • DHA supplementation improves retinal function in patients with LCHAD.

  • Lowering potentially toxic metabolites, the hydroxyacylcarnitines, in plasma slows the progression of retinopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Engel AG, Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science. 1973;179(76):899–902. PubMed PMID: 4687787, Epub 1973/03/02. eng.

    Article  CAS  PubMed  Google Scholar 

  2. DiMauro S, DiMauro PM. Muscle carnitine palmitoyltransferase deficiency and myoglobinuria. Science. 1973;182(115):929–31. PubMed PMID: 4745596, Epub 1973/11/20. eng.

    Article  CAS  PubMed  Google Scholar 

  3. Bank WJ, DiMauro S, Bonilla E, Capuzzi DM, Rowland LP. A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase. N Engl J Med. 1975;292(9):443–9. PubMed PMID: 123038, Epub 1975/02/27. eng.

    Article  CAS  PubMed  Google Scholar 

  4. DiMauro S, Papadimitriou A. Carnitine palmitoyltransferase deficiency. In: Engel A, Banker B, editors. Myology: basic and clinical. New York: McGraw-Hill; 1986. p. 1697.

    Google Scholar 

  5. Gillingham MB, Harding CO, Schoeller DA, Matern D, Purnell JQ. Altered body composition and energy expenditure but normal glucose tolerance among humans with a long-chain fatty acid oxidation disorder. Am J Physiol Endocrinol Metab. 2013;305(10):E1299–308. PubMed PMID: 24064340. Pubmed Central PMCID: PMC3840216. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Institute of Medicine (U.S.). Panel on Macronutrients, Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press; 2005. xxv, 1331 p.

    Google Scholar 

  7. Gillingham MB, Connor WE, Matern D, Rinaldo P, Burlingame T, Meeuws K, et al. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2003;79(2):114–23. PubMed PMID: 12809642. Pubmed Central PMCID: PMC2813192. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Poll-The BT, Bonnefont JP, Ogier H, Charpentier C, Pelet A, Le Fur JM, et al. Familial hypoketotic hypoglycaemia associated with peripheral neuropathy, pigmentary retinopathy and C6-C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation? J Inherit Metab Dis. 1988;11 Suppl 2:183–5. PubMed PMID: 2846959. Epub 1988/01/01.

    Article  PubMed  Google Scholar 

  9. Dionisi-Vici C, Burlina A, Bertini E, Bachmann C, Mazziotta MRM, Zacchello F, et al. Progressive neuropathy and recurrent, myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1991;118:744.

    Article  CAS  PubMed  Google Scholar 

  10. Przyrembel H, Jakobs C, Ijlst L, de Klerk JB, Wanders RJ. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1991;14(5):674–80. PubMed PMID: 1779613. Epub 1991/01/01. eng.

    Article  CAS  PubMed  Google Scholar 

  11. Wanders RJA, Ijlst L, Duran M, Jakobs C, Deklerk JBC, Przyrembel H, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency – different clinical expression in three unrelated patients. J Inherit Metab Dis. 1991;14(3):325–8.

    Article  CAS  PubMed  Google Scholar 

  12. Tserng KY, Jin SJ, Kerr DS, Hoppel CL. Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metab Clin Exp. 1991;40(7):676–82.

    Article  CAS  PubMed  Google Scholar 

  13. Tyni T, Kivela T, Lappi M, Summanen P, Nikoskelainen E, Pihko H. Ophthalmologic findings in long-chain 3-hydroxyacyl-Coa dehydrogenase deficiency caused by the G1528c mutation – a new type of hereditary metabolic chorioretinopathy. Ophthalmology. 1998;105(5):810–24.

    Article  CAS  PubMed  Google Scholar 

  14. Gillingham M, Van Calcar S, Ney D, Wolff J, Harding C. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey. J Inherit Metab Dis. 1999;22(2):123–31. PubMed PMID: 10234607, Pubmed Central PMCID: 2694044, Epub 1999/05/11. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Gillingham MB, Weleber RG, Neuringer M, Connor WE, Mills M, van Calcar S, et al. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab. 2005;86(1-2):124–33. PubMed PMID: 16040264. Pubmed Central PMCID: PMC2694051. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Baruteau J, Sachs P, Broue P, Brivet M, Abdoul H, Vianey-Saban C, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis. 2012;3. PubMed PMID: 23053472.

    Google Scholar 

  17. Fletcher AL, Pennesi ME, Harding CO, Weleber RG, Gillingham MB. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012;106(1):18–24. PubMed PMID: 22459206. Pubmed Central PMCID: PMC3506186. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Asp Med. 2004;25(5-6):495–520. PubMed PMID: 15363638. eng.

    Article  CAS  Google Scholar 

  19. Costa CG, Dorland L, Dealmeida IT, Jakobs C, Duran M, Pollthe BT. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-Coa dehydrogenase deficiency. J Inherit Metab Dis. 1998;21(4):391–9.

    Article  CAS  PubMed  Google Scholar 

  20. Duran M, Wanders RJ, de Jager JP, Dorland L, Bruinvis L, Ketting D, et al. 3-hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme a dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. Eur J Pediatr. 1991;150(3):190–5. PubMed PMID: 2044590, Epub 1991/01/01. eng.

    Article  CAS  PubMed  Google Scholar 

  21. Moore R, Glasgow JFT, Bingham MA, Dodge JA, Pollitt RJ, Olpin SE, et al. Long-chain 3-hydroxyacyl-coenzyme-a dehydrogenase deficiency – diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr. 1993;152(5):433–6.

    Article  CAS  PubMed  Google Scholar 

  22. Shen JJ, Matern D, Millington DS, Hillman S, Feezor MD, Bennett MJ, et al. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. J Inherit Metab Dis. 2000;23(1):27–44.

    Article  CAS  PubMed  Google Scholar 

  23. Fahnehjelm KT, Holmström G, Ying L, Haglind CB, Nordenström A, Halldin M, et al. Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up. Acta Ophthalmol. 2008;86(3):329–37. PubMed PMID: 18162058. eng.

    Article  PubMed  Google Scholar 

  24. Gillingham MB, Matern D, Harding CO. Effect of feeding, exercise and genotype on plasma 3-hydroxyacylcarnitines in children with lchad deficiency. Top Clin Nutr. 2009;24(4):359–65. PubMed PMID: 20589231. Pubmed Central PMCID: PMC2892921. ENG.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Wahren J. Glucose turnover during exercise in man. Ann N Y Acad Sci. 1977;301:45–55. PubMed PMID: 270932. eng.

    Article  CAS  PubMed  Google Scholar 

  26. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol. 1993;265(3 Pt 1):E380–91. PubMed PMID: 8214047. eng.

    CAS  PubMed  Google Scholar 

  27. Orngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology. 2003;61(4):559–61. PubMed PMID: 12939440. Epub 2003/08/27. eng.

    Article  PubMed  Google Scholar 

  28. Orngreen MC, Olsen DB, Vissing J. Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose. Neurology. 2002;59(7):1046–51. PubMed PMID: 12370460. Epub 2002/10/09. eng.

    Article  CAS  PubMed  Google Scholar 

  29. Jeukendrup AE, Thielen JJ, Wagenmakers AJ, Brouns F, Saris WH. Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization and subsequent cycling performance. Am J Clin Nutr. 1998;67(3):397–404. PubMed PMID: 9497182. eng.

    CAS  PubMed  Google Scholar 

  30. Odle J. New insights into the utilization of medium-chain triglycerides by the neonate: observations from a piglet model. J Nutr. 1997;127(6):1061–7. PubMed PMID: 9187618. eng.

    CAS  PubMed  Google Scholar 

  31. Odle J, Benevenga NJ, Crenshaw TD. Utilization of medium-chain triglycerides by neonatal piglets: chain length of even- and odd-carbon fatty acids and apparent digestion/absorption and hepatic metabolism. J Nutr. 1991;121(5):605–14. PubMed PMID: 2019870.

    CAS  PubMed  Google Scholar 

  32. Gillingham MB, Scott B, Elliott D, Harding CO. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Molecular Genetics Metab. 2006;89(1-2):58–63.

    Article  CAS  Google Scholar 

  33. Behrend AM, Harding CO, Shoemaker JD, Matern D, Sahn DJ, Elliot DL, et al. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab. 2012;105(1):110–5. PubMed PMID: 22030098, Pubmed Central PMCID: 3253922.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;110(25):3842–8. PubMed PMID: 15596567. eng.

    Article  CAS  PubMed  Google Scholar 

  35. Ruiz-Sanz JI, Aldamiz-Echevarria L, Arrizabalaga J, Aquino L, Jimeno P, Perez-Nanclares G, et al. Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil. J Inherit Metab Dis. 2001;24(4):493–503.

    Article  CAS  PubMed  Google Scholar 

  36. Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73(1):38–45. PubMed PMID: 11350181. eng.

    Article  CAS  PubMed  Google Scholar 

  37. Roe CR, Roe DS, Wallace M, Garritson B. Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders. Mol Genet Metab. 2007;92(4):346–50. PubMed PMID: 17825594. eng.

    Article  CAS  PubMed  Google Scholar 

  38. Harding CO, Gillingham MB, van Calcar SC, Wolff JA, Verhoeve JN, Mills MD. Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1999;22(3):276–80. PubMed PMID: 10384386. Pubmed Central PMCID: PMC2694039. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Tein I, Vajsar J, MacMillan L, Sherwood WG. Long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency neuropathy: response to cod liver oil. Neurology. 1999;52(3):640–3. PubMed PMID: 10025805. eng.

    Article  CAS  PubMed  Google Scholar 

  40. Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye (Lond). 1998;12(Pt 1):127–33. PubMed PMID: 9614529. eng.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melanie Boyd Gillingham PhD, RD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gillingham, M.B. (2015). Nutrition Studies in Long-Chain Fatty Acid Oxidation Disorders: Diet Composition and Monitoring. In: Bernstein, L., Rohr, F., Helm, J. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-14621-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14621-8_23

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14620-1

  • Online ISBN: 978-3-319-14621-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics